Scientists discover enzyme that could supercharge Ozempic-like weight-loss drugs
Scientists discover enzyme that could supercharge Ozempic-like weight-loss drugs New York PostUtah scientists find PapB could extend Ozempic and Wegovy effects NewsBytesScientists discover enzyme that could supercharge Ozempic ScienceDailyCould a ...
Google News AI
Source
Generated insight by OnAirToday AI
This discovery of the PapB enzyme could significantly enhance the efficacy and potentially lower the cost of GLP-1 agonist medications like Ozempic. By extending the drug's active period in the body, it may lead to improved patient outcomes and greater accessibility to these transformative treatments.
Get the day's AI news in one short email. Free.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.